Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Specialty Solutions Spotlight: Cybersecurity Risks With Internet Connected Medical Devices
Are internet-connected medical devices a cybersecurity risk? The advent of the
Workers' Comp
Article
Ask The Pharmacist: Fixed-Dose Combination Drugs in Workers’ Comp
Beyond convenience, are there advantages in the use of fixed-dose combination drug products? Fixed-dose combination drug products (FDCDPs
Workers' Comp
News Release
Enlyte’s 2024 Trends Report Addresses Top Challenges in the P&C Industry
Industry leaders offer unique data and strategies to address trending issues including generative AI, provider shortages, drug costs and regula
Workers' Comp
Conference
IAIABC Forum 2024
At The Forum, the IAIABC's committees and councils discuss policy and administrative issues in workers' compensation, and attendees may also take p
Workers' Comp
Conference
RIMS Annual Conference & Exhibition 2024
RIMS 2024 Annual Conference & Exhibition is the premier event for the risk management community. RIMS features not only the largest exhibi
Workers' Comp
Conference
WCRI Issues & Research Conference 2024
The WCRI conference is a leading workers’ compensation forum.